These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26017300)

  • 21. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.
    Rietscher R; Schröder M; Janke J; Czaplewska J; Gottschaldt M; Scherließ R; Hanefeld A; Schubert US; Schneider M; Knolle PA; Lehr CM
    Eur J Pharm Biopharm; 2016 May; 102():20-31. PubMed ID: 26940132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
    Delgado A; Lavelle EC; Hartshorne M; Davis SS
    Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants.
    Rafati H; Lavelle EC; Coombes AG; Stolnik S; Holland J; Davis SS
    Vaccine; 1997 Dec; 15(17-18):1888-97. PubMed ID: 9413098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.
    Pavot V; Berthet M; Rességuier J; Legaz S; Handké N; Gilbert SC; Paul S; Verrier B
    Nanomedicine (Lond); 2014 Dec; 9(17):2703-18. PubMed ID: 25529572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogen-Mimicking Polymeric Nanoparticles based on Dopamine Polymerization as Vaccines Adjuvants Induce Robust Humoral and Cellular Immune Responses.
    Liu Q; Jia J; Yang T; Fan Q; Wang L; Ma G
    Small; 2016 Apr; 12(13):1744-57. PubMed ID: 26849717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant.
    Jain S; O'Hagan DT; Singh M
    Expert Rev Vaccines; 2011 Dec; 10(12):1731-42. PubMed ID: 22085176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical imiquimod is a potent adjuvant to a weakly-immunogenic protein prototype vaccine.
    Johnston D; Bystryn JC
    Vaccine; 2006 Mar; 24(11):1958-65. PubMed ID: 16310898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A Virus.
    Kingstad-Bakke B; Toy R; Lee W; Pradhan P; Vogel G; Marinaik CB; Larsen A; Gates D; Luu T; Pandey B; Kawaoka Y; Roy K; Suresh M
    Front Immunol; 2020; 11():559382. PubMed ID: 33767689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles.
    Zhang XQ; Dahle CE; Weiner GJ; Salem AK
    J Pharm Sci; 2007 Dec; 96(12):3283-92. PubMed ID: 17497736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucan Particles Are a Powerful Adjuvant for the HBsAg, Favoring Antiviral Immunity.
    Soares E; Groothuismink ZMA; Boonstra A; Borges O
    Mol Pharm; 2019 May; 16(5):1971-1981. PubMed ID: 30964694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of protein-adjuvant coencapsulation in microparticles for vaccine delivery.
    Mathew S; Lendlein A; Wischke C
    Eur J Pharm Biopharm; 2014 Jul; 87(2):403-7. PubMed ID: 24747810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Immunoenhancement Effects of Polyethylenimine-Modified Chinese Yam Polysaccharide-Encapsulated PLGA Nanoparticles as an Adjuvant.
    Zhang Y; Gu P; Wusiman A; Xu S; Ni H; Qiu T; Liu Z; Hu Y; Liu J; Wang D
    Int J Nanomedicine; 2020; 15():5527-5543. PubMed ID: 32848386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen delivery by lipid-enveloped PLGA microparticle vaccines mediated by in situ vesicle shedding.
    Hanson MC; Bershteyn A; Crespo MP; Irvine DJ
    Biomacromolecules; 2014 Jul; 15(7):2475-81. PubMed ID: 24894061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66.
    Carcaboso AM; Hernández RM; Igartua M; Gascón AR; Rosas JE; Patarroyo ME; Pedraz JL
    Int J Pharm; 2003 Jul; 260(2):273-82. PubMed ID: 12842346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.
    Uchida T; Goto S
    Biol Pharm Bull; 1994 Sep; 17(9):1272-6. PubMed ID: 7841952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual dye in-vivo imaging of differentially charged PLGA carriers reveals antigen-depot effect, leading to improved immune responses in preclinical models.
    Riehl M; Harms M; Lucas H; Ebensen T; Guzmán CA; Mäder K
    Eur J Pharm Sci; 2018 May; 117():88-97. PubMed ID: 29408551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled release microparticles for vaccine development.
    O'Hagan DT; Jeffery H; Roberts MJ; McGee JP; Davis SS
    Vaccine; 1991 Oct; 9(10):768-71. PubMed ID: 1759495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation.
    Silva AL; Rosalia RA; Varypataki E; Sibuea S; Ossendorp F; Jiskoot W
    Vaccine; 2015 Feb; 33(7):847-54. PubMed ID: 25576216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
    Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
    Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A protective allergy vaccine based on CpG- and protamine-containing PLGA microparticles.
    Martínez Gómez JM; Fischer S; Csaba N; Kündig TM; Merkle HP; Gander B; Johansen P
    Pharm Res; 2007 Oct; 24(10):1927-35. PubMed ID: 17541735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.